Seeking Alpha
Profile| Send Message|
( followers)  
The biotechnology companies below recently have reported insider buying. I watch for companies that are seeing insider buying to help me find stocks that might be undervalued. Some of these companies have seen substantial insider buys. Biotechnology is often speculative, which makes it more reassuring when you see executives investing their own money in these stocks. Most of the biotech companies I follow have heavy insider selling, so it's refreshing to see the buying in these names. Often it makes sense to follow the insiders, so these companies are worth looking into as possible investments.
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) is trading around $9.25. Ligand is a biotechnology company based in California. These shares have traded in a range between $8.14 to $14.80 in the last 52 weeks. The 50 day moving average is $9.46 and the 200 day moving average is $9.33. LGND is estimated to earn about 26 cents per share in 2011. You can see the repeated insider buying here.

Dyax Corp. (NASDAQ:DYAX) is trading around $1.53. DYAX is a biotechnology company based in Massachussets. These shares have traded in a range between $1.44 to $4.14 in the last 52 weeks. The 50 day moving average is $1.86 and the 200 day moving average is $2.21. DYAX is estimated to lose about 36 cents per share in 2011. You can see the repeated insider buying here.

Bioclinica Inc. (NASDAQ:BIOC) is trading around $5.18. Bioclinica is a biotechnology company based in Pennsylvania. These shares have traded in a range between $3.13 to $5.46 in the last 52 weeks. The 50 day moving average is $4.56 and the 200 day moving average is $4.11. BIOC is estimated to earn about 21 cents per share in 2011. You can see the repeated insider buying here.

Synta Pharmaceuticals Inc. (NASDAQ:SNTA) is trading around $4.70. Synta is a biotechnology company based in California. These shares have traded in a range between $2.55 to $6.93 in the last 52 weeks. The 50 day moving average is $5.22 and the 200 day moving average is $4.14. SNTA is estimated to lose about $1.08 per share in 2011. You can see the repeated insider buying here.

Threshold Pharmaceuticals Inc. (NASDAQ:THLD) is trading around $1.73. Threshold is a biotechnology company based in California. These shares have traded in a range between 98 cents to $3.34 in the last 52 weeks. The 50 day moving average is $1.93 and the 200 day moving average is $1.44. THLD is estimated to lose about 56 cents per share in 2011. You can see the repeated insider buying here.

Chelsea Therapeutics (NASDAQ:CHTP) is trading around $3.74. CHTP is a biotechnology company based in North Carolina. These shares have traded in a range between $1.94 to $8.20 in the last 52 weeks. The 50 day moving average is $5.14 and the 200 day moving average is $4.64. CHTP is estimated to lose about 86 cents per share in 2011. You can see the repeated insider buying here.

Alimera Sciences (NASDAQ:ALIM) is trading around $7.08. Alimera is a biotechnology company based in Georgia. These shares have traded in a range between $6.30 to $12.70 in the last 52 weeks. The 50 day moving average is $8.75 and the 200 day moving average is $9.20. ALIM is estimated to lose about 85 cents per share in 2011. You can see the repeated insider buying here.

Cerus Corp. (NASDAQ:CERS) is trading around $2.50. Cerus is a biotechnology company based in California. These shares have traded in a range between $2.11 to $4.01 in the last 52 weeks. The 50 day moving average is $3.16 and the 200 day moving average is $3.10. CERS is estimated to lose about 25 cents per share in 2011. You can see the repeated insider buying here.

The data is sourced from Yahoo Finance. The information and data is believed to be accurate, but no guarantees or representations are made. Rougemont is not a registered investment advisor and does not provide specific investment advice. The information contained herein is for informational purposes.

Source: Low-Priced Biotech Stocks With Insider Buying